China National Accord Medicines Corp Ltd
SZSE:000028
China National Accord Medicines Corp Ltd
Research & Development
China National Accord Medicines Corp Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Research & Development
-¥30.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Sinopharm Group Co Ltd
HKEX:1099
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Research & Development
-¥2.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Research & Development
-¥201.9m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Research & Development
-¥68.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
Huadong Medicine Co Ltd
SZSE:000963
|
Research & Development
-¥1.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
See Also
What is China National Accord Medicines Corp Ltd's Research & Development?
Research & Development
-30.9m
CNY
Based on the financial report for Mar 31, 2024, China National Accord Medicines Corp Ltd's Research & Development amounts to -30.9m CNY.
What is China National Accord Medicines Corp Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-173%
Over the last year, the Research & Development growth was -173%.